BR112017003444A2 - Composições farmacêuticas, e usos de agentes antibacterianos - Google Patents
Composições farmacêuticas, e usos de agentes antibacterianosInfo
- Publication number
- BR112017003444A2 BR112017003444A2 BR112017003444A BR112017003444A BR112017003444A2 BR 112017003444 A2 BR112017003444 A2 BR 112017003444A2 BR 112017003444 A BR112017003444 A BR 112017003444A BR 112017003444 A BR112017003444 A BR 112017003444A BR 112017003444 A2 BR112017003444 A2 BR 112017003444A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical compositions
- antibacterial agents
- pharmaceutically acceptable
- acceptable derivative
- doripenem
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- JUZNIMUFDBIJCM-ANEDZVCMSA-N Invanz Chemical compound O=C([C@H]1NC[C@H](C1)SC=1[C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)NC1=CC=CC(C(O)=O)=C1 JUZNIMUFDBIJCM-ANEDZVCMSA-N 0.000 abstract 1
- WKDDRNSBRWANNC-UHFFFAOYSA-N Thienamycin Natural products C1C(SCCN)=C(C(O)=O)N2C(=O)C(C(O)C)C21 WKDDRNSBRWANNC-UHFFFAOYSA-N 0.000 abstract 1
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229960000895 doripenem Drugs 0.000 abstract 1
- AVAACINZEOAHHE-VFZPANTDSA-N doripenem Chemical compound C=1([C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)S[C@@H]1CN[C@H](CNS(N)(=O)=O)C1 AVAACINZEOAHHE-VFZPANTDSA-N 0.000 abstract 1
- 229960002770 ertapenem Drugs 0.000 abstract 1
- ZSKVGTPCRGIANV-ZXFLCMHBSA-N imipenem Chemical compound C1C(SCC\N=C\N)=C(C(O)=O)N2C(=O)[C@H]([C@H](O)C)[C@H]21 ZSKVGTPCRGIANV-ZXFLCMHBSA-N 0.000 abstract 1
- 229960002182 imipenem Drugs 0.000 abstract 1
- 229960002260 meropenem Drugs 0.000 abstract 1
- DMJNNHOOLUXYBV-PQTSNVLCSA-N meropenem Chemical compound C=1([C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)S[C@@H]1CN[C@H](C(=O)N(C)C)C1 DMJNNHOOLUXYBV-PQTSNVLCSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
COMPOSIÇÕES FARMACÊUTICAS, E USOS DE AGENTES ANTIBACTERIANOS. A presente invenção refere-se a composições farmacêuticas compreendendo: (a) um agente antibacteriano carbapenem selecionado dentre imipenem, meropenem, ertapenem, doripenem ou um derivado farmaceuticamente aceitável do mesmo, e (b) um composto de fórmula (I), ou um estereoisômero ou um derivado farmaceuticamente aceitável do mesmo.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN193/MUM/2014 | 2014-01-21 | ||
| IN193MU2014 IN2014MU00193A (pt) | 2014-01-21 | 2015-01-20 | |
| PCT/IB2015/050421 WO2015110950A1 (en) | 2014-01-21 | 2015-01-20 | Pharmaceutical compositions comprising antibacterial agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112017003444A2 true BR112017003444A2 (pt) | 2023-03-07 |
| BR112017003444B1 BR112017003444B1 (pt) | 2024-05-28 |
Family
ID=
Also Published As
| Publication number | Publication date |
|---|---|
| AU2015208830A1 (en) | 2017-04-27 |
| RU2017110457A (ru) | 2018-10-03 |
| CA2954553C (en) | 2022-12-06 |
| IN2014MU00193A (pt) | 2015-08-28 |
| EP3217979B8 (en) | 2020-06-03 |
| ES2804500T3 (es) | 2021-02-08 |
| US10322116B2 (en) | 2019-06-18 |
| US20180104224A1 (en) | 2018-04-19 |
| EP3217979A1 (en) | 2017-09-20 |
| CA2954553A1 (en) | 2015-07-30 |
| US20170202813A1 (en) | 2017-07-20 |
| NZ728036A (en) | 2019-12-20 |
| RU2705375C2 (ru) | 2019-11-07 |
| WO2015110950A1 (en) | 2015-07-30 |
| EP3217979B1 (en) | 2020-04-08 |
| AU2020201956B2 (en) | 2020-07-09 |
| ZA201700064B (en) | 2018-08-29 |
| AU2020201956A1 (en) | 2020-04-02 |
| RU2017110457A3 (pt) | 2018-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018502747A1 (en) | Boronic acid derivatives and therapeutic uses thereof | |
| PH12015502013B1 (en) | Pharmaceutical composition of s-ketamine hydrochloride | |
| PH12015501957A1 (en) | Pharmaceutical composition of s-ketamine hydrochloride | |
| EP4230264A3 (en) | Prodrugs of fumarates and their use in treating various deseases | |
| EP3256153A4 (en) | Formulations for oral administration of active agents with controlled absorption profile | |
| WO2014205389A8 (en) | Nuclear transport modulators and uses thereof | |
| MY197698A (en) | Oxysterols and methods of use thereof | |
| DOP2016000253A (es) | Nuevos compuestos | |
| BR112017000246A2 (pt) | composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, e, uso de um composto ou de um sal | |
| BR112016024235A2 (pt) | composições farmacêuticas compreendendo agentes antibacterianos | |
| EP3417853A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CANCER CONTAINING POLYPHENOL COMPOUND AS ACTIVE INGREDIENT | |
| PH12017500459A1 (en) | Azetidinyloxyphenylpyrrolidine compounds | |
| BR112018074985A2 (pt) | composições antibacterianas | |
| MX2017010422A (es) | Imidazolil enonas triciclicas como moduladores de inflamacion antioxidantes. | |
| BR112017004580A2 (pt) | composto, composição farmacêutica, produto de combinação, uso de um composto ou sal farmaceuticamente aceitável, e, método de tratamento. | |
| PE20150167A1 (es) | (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel | |
| DOP2016000251A (es) | Inhibidores de las vías de señalización de wnt | |
| MX2017013099A (es) | Metodos para el tratamiento de trastornos inflamatorios. | |
| BR112017026904A2 (pt) | formulações farmacêuticas injetáveis de lefamulina | |
| MX2016005160A (es) | Composiciones farmaceuticas que comprenden agentes antibacterianos. | |
| PH12015502703A1 (en) | Pharmaceutical compositions | |
| NZ719215A (en) | Pharmaceutical compositions comprising antibacterial agents | |
| BR112017003444A2 (pt) | Composições farmacêuticas, e usos de agentes antibacterianos | |
| MX2016005539A (es) | Composiciones farmaceuticas que comprenden agentes antibacterianos. | |
| MX360040B (es) | Nuevo agente antibacteriano derivado de florfenicol unido a sulfoximina y el uso del mismo en el tratamiento de infecciones bacterianas en ganado vacuno. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B12F | Other appeals [chapter 12.6 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/01/2015, OBSERVADAS AS CONDICOES LEGAIS |